# A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults

> **NCT07456059** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Edgewise Therapeutics, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** EDG-7500

## Key facts

- **NCT ID:** NCT07456059
- **Lead sponsor:** Edgewise Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07456059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07456059, "A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07456059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*